{"id":"incobotulinumtoxin-a","safety":{"commonSideEffects":[{"rate":"10%","effect":"Headache"},{"rate":"5%","effect":"Muscle weakness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"This toxin specifically targets and binds to presynaptic nerve terminals, inhibiting the release of acetylcholine, which results in a reversible blockage of neuromuscular transmission and subsequent muscle relaxation.","oneSentence":"Incobotulinumtoxin A is a neurotoxin that blocks the release of acetylcholine at neuromuscular junctions, leading to temporary muscle paralysis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:36:02.646Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cervical dystonia"},{"name":"Blepharospasm"},{"name":"Glabellar lines"}]},"trialDetails":[{"nctId":"NCT03992404","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merz Pharmaceuticals GmbH","startDate":"2019-09-16","conditions":"Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury","enrollment":603},{"nctId":"NCT07473635","phase":"NA","title":"Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study","status":"RECRUITING","sponsor":"Bo Biering-Soerensen","startDate":"2026-01-07","conditions":"CRPS (Complex Regional Pain Syndromes), CRPS (Complex Regional Pain Syndrome) Type I, CRPS Type II","enrollment":20},{"nctId":"NCT05623111","phase":"PHASE2","title":"Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2023-08-01","conditions":"Diabetic Neuropathy, Painful","enrollment":80},{"nctId":"NCT04075981","phase":"PHASE3","title":"Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2019-09-30","conditions":"Cardiac Surgery","enrollment":220},{"nctId":"NCT04766723","phase":"PHASE2","title":"A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm","status":"COMPLETED","sponsor":"Merz Pharmaceuticals GmbH","startDate":"2021-02-24","conditions":"Essential Tremor of the Upper Limb","enrollment":78},{"nctId":"NCT05456087","phase":"PHASE2","title":"Use of Botulinum Toxin in the Treatment of Androgenic Alopecia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zel Skin and Laser Specialists","startDate":"2022-08-12","conditions":"Androgenetic Alopecia","enrollment":20},{"nctId":"NCT05980559","phase":"PHASE3","title":"Evaluation of BTX Injections in Treatment of Bruxism","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2024-01-15","conditions":"Bruxism","enrollment":12},{"nctId":"NCT04922983","phase":"PHASE2","title":"Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis","status":"UNKNOWN","sponsor":"Manhattan Physical Medicine and Rehabilitation, LLP","startDate":"2021-07-01","conditions":"Scoliosis Idiopathic, Scoliosis; Adolescence, Scoliosis; Lumbar Region","enrollment":42},{"nctId":"NCT02107261","phase":"PHASE2","title":"Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-03","conditions":"Dystonia","enrollment":21},{"nctId":"NCT05623410","phase":"PHASE3","title":"Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines","status":"UNKNOWN","sponsor":"ATGC Co., Ltd.","startDate":"2022-10-11","conditions":"Glabellar Frown Lines","enrollment":300},{"nctId":"NCT04148872","phase":"PHASE4","title":"Mixed Methods Investigation of Chronic Facial Paralysis in Individuals With Synkinesis","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2019-10-24","conditions":"Synkinesis","enrollment":15},{"nctId":"NCT05340439","phase":"PHASE2","title":"INcobotulinumtoxina in ChIldren Upper and Lower Limb sPasticITy (INCIPIT)","status":"UNKNOWN","sponsor":"Universita di Verona","startDate":"2022-06","conditions":"Spastic Cerebral Palsy","enrollment":30},{"nctId":"NCT04792398","phase":"PHASE4","title":"Bruxism Xeomin® Intervention Trial","status":"UNKNOWN","sponsor":"Dominik Ettlin","startDate":"2021-05-01","conditions":"Sleep Bruxism, Adult","enrollment":6},{"nctId":"NCT03758235","phase":"PHASE3","title":"Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin","status":"UNKNOWN","sponsor":"University Of Perugia","startDate":"2018-09-01","conditions":"Overactive Bladder Syndrome","enrollment":140},{"nctId":"NCT02728778","phase":"PHASE2","title":"Botulinum Toxin A for Emotional Stabilization in Borderline Personality Disorder (BPD)","status":"COMPLETED","sponsor":"Hannover Medical School","startDate":"2016-09-01","conditions":"Borderline Personality Disorder","enrollment":54},{"nctId":"NCT02444169","phase":"","title":"Retrospective Evaluation of Combination Treatment With the Ulthera System","status":"COMPLETED","sponsor":"Ulthera, Inc","startDate":"2015-04","conditions":"Skin Laxity","enrollment":101},{"nctId":"NCT01905683","phase":"PHASE3","title":"Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy","status":"COMPLETED","sponsor":"Merz Pharmaceuticals GmbH","startDate":"2013-08","conditions":"Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy","enrollment":370},{"nctId":"NCT03048383","phase":"PHASE4","title":"Comparison of Three Botulinum Neuromodulators for Management of Facial Synkinesis","status":"COMPLETED","sponsor":"University of Utah","startDate":"2012-07","conditions":"Facial Nerve Injuries, Facial Paresis Associated With Facial Nerve Dysfunction, Facial Asymmetry","enrollment":71},{"nctId":"NCT01968902","phase":"PHASE4","title":"Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients","status":"COMPLETED","sponsor":"Multiple Sclerosis Center of Northeastern New York","startDate":"2013-11","conditions":"Muscle Spasticity, Multiple Sclerosis","enrollment":27},{"nctId":"NCT01931878","phase":"PHASE2","title":"Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.","status":"COMPLETED","sponsor":"Yale University","startDate":"2012-09","conditions":"Restless Leg Syndrome","enrollment":24},{"nctId":"NCT01842529","phase":"PHASE2","title":"Botulinum Toxin Injection in Epicardial Fat Pads To Treat Atrial Fibrillation After Cardiac Surgery","status":"COMPLETED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2012-09","conditions":"Paroxysmal Atrial Fibrillation, Indications for CABG","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Xeomin","Botox"],"phase":"phase_2","status":"active","brandName":"Incobotulinumtoxin A","genericName":"Incobotulinumtoxin A","companyName":"Ulthera, Inc","companyId":"ulthera-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Incobotulinumtoxin A is a neurotoxin that blocks the release of acetylcholine at neuromuscular junctions, leading to temporary muscle paralysis. Used for Cervical dystonia, Blepharospasm, Glabellar lines.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}